Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Optimal use of available claims to identify a Medicare population free of coronary heart disease.

Kent ST, Safford MM, Zhao H, Levitan EB, Curtis JR, Kilpatrick RD, Kilgore ML, Muntner P.

Am J Epidemiol. 2015 Nov 1;182(9):808-19. doi: 10.1093/aje/kwv116. Epub 2015 Oct 5.

2.

A Retrospective Study Of Mortality In Risk Patients With High Dose Statin Usage And No Statin Usage.

Sandberg J, Jørgensen L, Taylor B, Kilpatrick RD, Sobocki P.

Value Health. 2014 Nov;17(7):A478. doi: 10.1016/j.jval.2014.08.1379. Epub 2014 Oct 26. No abstract available.

3.

The authors reply.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2014 Sep;86(3):649. doi: 10.1038/ki.2014.160. No abstract available.

4.

Response to High rates of death and hospitalization follow bone fracture among hemodialysis patients.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2013 Jul 31;85(1):166-173. No abstract available.

5.

CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.

Block GA, Kilpatrick RD, Lowe KA, Wang W, Danese MD.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2132-40. doi: 10.2215/CJN.04260413. Epub 2013 Sep 19.

6.

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ; HF-ACTION Investigators.

Clin Cardiol. 2013 Oct;36(10):611-20. doi: 10.1002/clc.22181. Epub 2013 Aug 8.

7.

High rates of death and hospitalization follow bone fracture among hemodialysis patients.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2014 Jan;85(1):166-73. doi: 10.1038/ki.2013.279. Epub 2013 Jul 31.

8.

Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients.

Newsome BB, Kilpatrick RD, Liu J, Zaun D, Solid CA, Nieman K, St Peter WL.

Am J Nephrol. 2013;38(2):104-14. doi: 10.1159/000353298. Epub 2013 Jul 30.

9.

Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients.

Beaubrun AC, Kilpatrick RD, Freburger JK, Bradbury BD, Wang L, Brookhart MA.

J Am Soc Nephrol. 2013 Sep;24(9):1461-9. doi: 10.1681/ASN.2012090916. Epub 2013 Jun 6.

10.

Association between hemoglobin level and cardiopulmonary performance in heart failure: insights from the HF-ACTION study.

Cohen-Solal A, Keteyian SJ, Horton JR, Ellis SJ, Kraus WE, Kilpatrick RD.

Int J Cardiol. 2013 Oct 9;168(4):4357-9. doi: 10.1016/j.ijcard.2013.05.070. Epub 2013 Jun 2. No abstract available.

PMID:
23735344
11.

Trends in hip fracture rates in US hemodialysis patients, 1993-2010.

Arneson TJ, Li S, Liu J, Kilpatrick RD, Newsome BB, St Peter WL.

Am J Kidney Dis. 2013 Oct;62(4):747-54. doi: 10.1053/j.ajkd.2013.02.368. Epub 2013 Apr 28.

PMID:
23631997
12.

Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients.

Kilpatrick RD, Newsome BB, Zaun D, Liu J, Solid CA, Nieman K, St Peter WL.

Am J Nephrol. 2013;37(4):389-98. doi: 10.1159/000350213. Epub 2013 Mar 29.

PMID:
23548469
13.

Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Bowling CB, Muntner P, Bradbury BD, Kilpatrick RD, Isitt JJ, Warriner AH, Curtis JR, Judd S, Brown CJ, Allman RM, Warnock DG, McClellan W.

Am J Med Sci. 2013 Jun;345(6):446-54. doi: 10.1097/MAJ.0b013e3182638364.

14.

Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions.

Kilpatrick RD, Gilbertson D, Brookhart MA, Polley E, Rothman KJ, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):111-21. doi: 10.1002/pds.3297. Epub 2012 Jun 4.

PMID:
22674782
15.

Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.

Bradbury BD, Gilbertson DT, Brookhart MA, Kilpatrick RD.

Adv Chronic Kidney Dis. 2012 Jan;19(1):19-26. doi: 10.1053/j.ackd.2012.01.001. Review.

PMID:
22364797
16.

The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover study.

Kilpatrick RD, Danese MD, Belozeroff V, Smirnakis K, Goodman WG, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):914-21. doi: 10.1002/pds.2183. Epub 2011 Jul 7.

PMID:
21735509
17.

The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.

Rickabaugh TM, Kilpatrick RD, Hultin LE, Hultin PM, Hausner MA, Sugar CA, Althoff KN, Margolick JB, Rinaldo CR, Detels R, Phair J, Effros RB, Jamieson BD.

PLoS One. 2011 Jan 26;6(1):e16459. doi: 10.1371/journal.pone.0016459.

18.

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.

Wang O, Kilpatrick RD, Critchlow CW, Ling X, Bradbury BD, Gilbertson DT, Collins AJ, Rothman KJ, Acquavella JF.

Clin J Am Soc Nephrol. 2010 Feb;5(2):182-8. doi: 10.2215/CJN.03040509. Epub 2009 Dec 17.

19.

Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.

Bradbury BD, Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ.

Am J Kidney Dis. 2009 Sep;54(3):554-60. doi: 10.1053/j.ajkd.2009.05.010. Epub 2009 Jul 9. Review.

PMID:
19592144
20.

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD.

Clin J Am Soc Nephrol. 2008 Jul;3(4):1077-83. doi: 10.2215/CJN.04601007. Epub 2008 Apr 16.

21.

Homeostasis of the naive CD4+ T cell compartment during aging.

Kilpatrick RD, Rickabaugh T, Hultin LE, Hultin P, Hausner MA, Detels R, Phair J, Jamieson BD.

J Immunol. 2008 Feb 1;180(3):1499-507.

22.

Hepatitis C virus and death risk in hemodialysis patients.

Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S.

J Am Soc Nephrol. 2007 May;18(5):1584-93. Epub 2007 Apr 11.

23.

Association between serum lipids and survival in hemodialysis patients and impact of race.

Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K.

J Am Soc Nephrol. 2007 Jan;18(1):293-303. Epub 2006 Dec 13.

24.

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.

Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD.

Kidney Int. 2006 Aug;70(4):771-80. Epub 2006 Jul 5.

25.

Longitudinal associations between dietary protein intake and survival in hemodialysis patients.

Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K.

Am J Kidney Dis. 2006 Jul;48(1):37-49.

PMID:
16797385
26.

Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.

Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K.

J Am Soc Nephrol. 2006 Apr;17(4):1181-91.

27.

A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls.

Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, Stringer WW.

Hemodial Int. 2005 Jul;9(3):314-24.

PMID:
16191083
28.

Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.

Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S.

Am J Kidney Dis. 2005 Sep;46(3):489-500.

PMID:
16129211
29.

Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.

Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S.

Nephrol Dial Transplant. 2005 Sep;20(9):1880-8. Epub 2005 Jun 14.

PMID:
15956056
30.

Reverse epidemiology of blood pressure in dialysis patients.

Kalantar-Zadeh K, Kilpatrick RD, Kopple JD.

Kidney Int. 2005 May;67(5):2067; author reply 2067-8. No abstract available.

31.

Survival advantages of obesity in dialysis patients.

Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB.

Am J Clin Nutr. 2005 Mar;81(3):543-54. Review.

PMID:
15755821
32.

Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.

Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD.

Hypertension. 2005 Apr;45(4):811-7. Epub 2005 Feb 7.

PMID:
15699452
33.

Reverse epidemiology: a spurious hypothesis or a hardcore reality?

Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY.

Blood Purif. 2005;23(1):57-63. Review.

PMID:
15627738
34.

'Wellness' helps public and industry.

Kilpatrick RD.

Natl Underwrit Life Health. 1984 Dec 1;88(48):13, 20. No abstract available.

PMID:
10269199
35.

Saving lives and money. Wellness programs make good sense for business and employees.

Kilpatrick RD.

Bus Insur. 1984 Nov 19;18(47):21. No abstract available.

PMID:
10268501

Supplemental Content

Loading ...
Support Center